Used in pharmaceutical research as a potent and selective inhibitor of fatty acid amide hydrolase (FAAH), an enzyme responsible for the breakdown of endocannabinoids like anandamide. By inhibiting FAAH, it increases endocannabinoid levels in the brain, leading to potential therapeutic effects in pain management, anxiety, and inflammation without the psychoactive effects associated with cannabinoid receptor agonists. It serves as a key compound in developing treatments targeting the endocannabinoid system. Also used as a reference standard in metabolic and enzymatic studies.